reference/20902373

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/20902373

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
endingPage	4163
issn	0027-8424 1091-6490
issueIdentifier	15
pageRange	4158-4163
publicationName	Proceedings of the National Academy of Sciences of the United States of America
startingPage	4158
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b64bd0ef32f3f9eefe02b23f5fed0e2b http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_646053f067e526d9b7ffd3f561e9edfc http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_2d51044db17774d5de40a92ecd76eada http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_91b360df9f5e4346bb40fb2ec976505e http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_6f74b7cda00f6e1592010ae8280dc7d0
bibliographicCitation	Zhang Y, Yang Y, Hosaka K, Huang G, Zang J, Chen F, Zhang Y, Samani NJ, Cao Y. Endocrine vasculatures are preferable targets of an antitumor ineffective low dose of anti-VEGF therapy. Proc Natl Acad Sci U S A. 2016 Apr 12;113(15):4158–63. PMID: 27035988; PMCID: PMC4839458.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-1551-9828 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_005d4483ad859172af45a825b57d0ae3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4c04c483a6a0ec7254507b009a4ec1e4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e8b8dc4213c8a81fb6c63cf172f7730a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6458959ec9ea3cfe72d3070c4b88d643 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f4377a3155211146e9b135bf5ea8f997 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_870da2344be141d61039cb16b95e1b18 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-5591-645X http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9137fe389d3788dfc8786b5f58f9a09a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2aea21ac1e587b29d5488d2580663041 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c78f13bdfe1aaefca22d04eddfcff6cb
date	2016-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/27035988 https://pubmed.ncbi.nlm.nih.gov/PMC4839458 https://doi.org/10.1073/pnas.1601649113
isPartOf	https://portal.issn.org/resource/ISSN/1091-6490 https://portal.issn.org/resource/ISSN/0027-8424 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/6653
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Endocrine vasculatures are preferable targets of an antitumor ineffective low dose of anti-VEGF therapy
discusses	http://id.nlm.nih.gov/mesh/M0356369 http://id.nlm.nih.gov/mesh/M0328153
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D042461Q000037 http://id.nlm.nih.gov/mesh/D009369Q000098 http://id.nlm.nih.gov/mesh/D004702Q000098 http://id.nlm.nih.gov/mesh/D020533Q000494
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D008810 http://id.nlm.nih.gov/mesh/D004305 http://id.nlm.nih.gov/mesh/D051379 http://id.nlm.nih.gov/mesh/D020533Q000627 http://id.nlm.nih.gov/mesh/D045744 http://id.nlm.nih.gov/mesh/D004702Q000503 http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D009369Q000188
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7296 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8102 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_714b3f52d8149c3277181d9513b93112 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607

Total number of triples: 55.